Cladribine Safety Questions, Cladribine Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Cladribine side effects. Check out Health Surveys and Health Polls. If you have questions about Cladribine, you can post them to our Doctors or Ask Patient Community about Cladribine.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Cladribine
Cladribine Safety Reports
Total Cladribine reports: 8.Cladribine FDA safety alerts: No.
Reported deaths: 2 Reported hospitalizations: 5.
Take Cladribine Side Effects Survey or Share Your Cladribine Story.
Reported Cladribine Side Effects: pancytopenia, urine output decreased, respiratory failure, renal impairment, hypoalbuminaemia, disseminated cytomegaloviral infection, oesophageal carcinoma, metastases to liver, metastases to bone, hepatic enzyme increased, swelling face.
Cladribine Usage.
Cladribine Side Effects Report #5262612-5
Consumer or non-health professional from TUNISIA reported CLADRIBINE problem on Feb 19, 2007. Female patient, 56 years of age, was diagnosed with multiple sclerosis and was treated with CLADRIBINE. After drug was administered, patient experienced the following problems/side effects: hepatitis acute. CLADRIBINE dosage: (0.875 MG/KG, 7 IN 1 CYCLE, ORAL. Patient was hospitalized. Patient recovered.
Cladribine Side Effects Report #5268594-4
CLADRIBINE problem was reported by a Health Professional from UNITED STATES on Mar 15, 2007. Male patient, 77 years of age, weighting 217.0 lb, was diagnosed with hairy cell leukaemia and was treated with CLADRIBINE. After drug was administered, patient experienced the following problems/side effects: extravasation, injection site reaction. CLADRIBINE dosage: 8.8 MG/DAY IV IN 500 ML NS CONTINUOUS INFUSION X 7 DAYS. Patient recovered.
Cladribine Side Effects Report #5315720-4
Consumer or non-health professional from UNITED STATES reported CLADRIBINE problem on Apr 30, 2007. Female patient, 39 years of age, was diagnosed with hairy cell leukaemia and was treated with CLADRIBINE. After drug was administered, patient experienced the following problems/side effects: pancytopenia. CLADRIBINE dosage: 0.09MG/KG IV. Patient was hospitalized. Patient recovered.
Cladribine Side Effects Report #5082728-6
CLADRIBINE problem was reported by a Pharmacist from UNITED STATES on Aug 16, 2006. Male patient, 64 years of age, weighting 203.0 lb, was diagnosed with hairy cell leukaemia, febrile neutropenia and was treated with CLADRIBINE. After drug was administered, patient experienced the following problems/side effects: cytokine storm, dyspnoea, febrile neutropenia, hypotension, thrombophlebitis superficial. CLADRIBINE dosage: unknown. During the same period patient was treated with ZOSYN, ADVICOR, PROZAC. Patient was hospitalized. Patient recovered.
Cladribine Side Effects Report #5110956-X
Health Professional from UNITED STATES reported CLADRIBINE problem on Sept 20, 2006. Female patient was diagnosed with malignant melanoma and was treated with CLADRIBINE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, blood glucose increased, coombs test positive, haemoglobin decreased, reticulocyte count increased. CLADRIBINE dosage: 0.12 MG/KG QD SQ #5. During the same period patient was treated with LISINOPRIL, NORCO. Patient was hospitalized. Patient recovered.
Cladribine Side Effects Report #5115453-3
CLADRIBINE problem was reported by a Consumer or non-health professional from GERMANY on Sept 07, 2006. Female patient, 19 years of age, was diagnosed with relapsing-remitting multiple sclerosis and was treated with CLADRIBINE. After drug was administered, patient experienced the following problems/side effects: diplopia, erythema, eye irritation, headache, hypersensitivity, mouth ulceration, mucosal ulceration, skin reaction, swelling face. CLADRIBINE dosage: 1 FORMS (0.875 MG/KG, 5 IN 1 CYCLE) ORAL. During the same period patient was treated with IMPLANON. Patient recovered.
Cladribine Side Effects Report #5192269-3
Physician from UNITED STATES reported CLADRIBINE problem on Dec 22, 2006. Male patient, weighting 262.0 lb, was diagnosed with multiple sclerosis and was treated with CLADRIBINE. After drug was administered, patient experienced the following problems/side effects: hepatic enzyme increased, metastases to bone, metastases to liver, oesophageal carcinoma. CLADRIBINE dosage: unknown. During the same period patient was treated with NOVANTRONE, COPAXONE, ATORVASTATIN, METFORMIN, LISINOPRIL, ASPIRIN, AMITRIPTYLINE. Patient was hospitalized. Patient died on 09/24/2006.
Cladribine Side Effects Report #5449048-9
CLADRIBINE problem was reported by a Physician from JAPAN on Sept 03, 2007. Male patient was diagnosed with mantle cell lymphoma, prophylaxis and was treated with CLADRIBINE. After drug was administered, patient experienced the following problems/side effects: disseminated cytomegaloviral infection, hypoalbuminaemia, pancytopenia, renal impairment, respiratory failure, urine output decreased. CLADRIBINE dosage: unknown. During the same period patient was treated with NOVANTRONE, BAKTAR, RITUXAN. Patient died on 04/07/2007.